USPTO grants patent to Stempeutics for stem cell drug Stempeucel
Posted by
www.biotecnika.org
"The US patent is for the method of treating ischemia by administering
pooled allogeneic mesenchymal stromal cells," Stempeutics Research
said in a statement. Critical Limb Ischemia is a severe blockage in
the arteries which results in reduced blood flow which in turn may
result in poor quality of life.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/uspto-grants-patent-to-stempeutics-for-stem-cell-drug-stempeucel/articleshow/71851014.cms
Subscribe to:
Post Comments (Atom)
Post a Comment